Predictions
Nanorepro AG
Start price
Target price
Perf. (%)
€6.38
10.01.22
10.01.22
€7.50
10.01.23
10.01.23
-64.19%
10.01.23
10.01.23
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Higher risks for its business
Bio-Gate AG
Start price
Target price
Perf. (%)
€4.14
09.01.22
09.01.22
-
09.01.23
09.01.23
-5.80%
23.01.22
23.01.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€19.50
06.01.22
06.01.22
-
06.01.23
06.01.23
-45.13%
13.03.22
13.03.22
Bio-Gate AG
Start price
Target price
Perf. (%)
€3.84
07.12.21
07.12.21
€5.00
07.12.22
07.12.22
-19.79%
08.12.22
08.12.22
Could be worthwhile Investment >10% per year
Nanorepro AG
Start price
Target price
Perf. (%)
€9.94
29.11.21
29.11.21
-
29.11.25
29.11.25
-83.35%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€18.36
27.11.21
27.11.21
€19.00
27.11.22
27.11.22
-50.44%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
CytoTools AG
Start price
Target price
Perf. (%)
€8.50
01.11.21
01.11.21
-
01.11.22
01.11.22
-78.94%
02.11.22
02.11.22
Probably not worthwhile Investment
Bio-Gate AG
Start price
Target price
Perf. (%)
€4.40
26.09.21
26.09.21
-
26.09.22
26.09.22
-6.82%
03.10.21
03.10.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Bio-Gate AG
Start price
Target price
Perf. (%)
€3.30
02.06.21
02.06.21
-
02.06.22
02.06.22
9.09%
20.06.21
20.06.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Bio-Gate AG
Start price
Target price
Perf. (%)
€3.70
02.05.21
02.05.21
-
02.05.22
02.05.22
1.08%
16.05.21
16.05.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€7.24
25.03.21
25.03.21
€12.00
25.03.22
25.03.22
-26.11%
26.11.21
26.11.21
Nanorepro AG
Start price
Target price
Perf. (%)
€16.00
12.03.21
12.03.21
€22.00
12.03.22
12.03.22
-62.19%
12.08.21
12.08.21
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Higher risks for its business
Nanorepro AG
Start price
Target price
Perf. (%)
€18.60
06.03.21
06.03.21
-
06.03.22
06.03.22
-59.84%
21.12.21
21.12.21
Could be very worthwhile Investment >20% year
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€8.98
21.02.21
21.02.21
€10.00
21.02.22
21.02.22
-54.90%
22.02.22
22.02.22
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Known brand
Very Future proof/growth oriented business model
Bio-Gate AG
Start price
Target price
Perf. (%)
€4.22
21.02.21
21.02.21
-
21.02.22
21.02.22
-5.21%
06.03.21
06.03.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€8.24
18.02.21
18.02.21
€15.00
18.02.22
18.02.22
-31.31%
19.10.21
19.10.21
Nanorepro AG
Start price
Target price
Perf. (%)
€8.95
16.02.21
16.02.21
€5.00
16.02.22
16.02.22
-7.49%
18.10.21
18.10.21
Below average Management
Little innovation
Few uniques
Dependend from some customers or products
Nanorepro AG
Start price
Target price
Perf. (%)
€8.60
15.02.21
15.02.21
€20.00
15.02.22
15.02.22
5.47%
23.09.21
23.09.21
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected